Evidence map›Paper›PMID 36556814›Full record

ArticleMaterials (Basel, Switzerland)2022

Density-Controlled Growth of ZnO Nanowalls for High-Performance Photocatalysts.

Yu-Cheng Chang, Ying-Ru Lin, Sheng-Wen Chen, Chia-Man Chou

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yu-Cheng ChangDepartment of Materials Science and Engineering, Feng Chia University, Taichung 407102, Taiwan.ORCID 0000-0001-5474-680X
Ying-Ru LinDepartment of Materials Science and Engineering, Feng Chia University, Taichung 407102, Taiwan.
Sheng-Wen ChenDepartment of Materials Science and Engineering, Feng Chia University, Taichung 407102, Taiwan.
Chia-Man ChouDepartment of Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan.ORCID 0000-0003-4616-437X
Feng Chia University · TWNational Yang Ming Chiao Tung University · TW

Funding

Ministry of Science and Technology, Taiwan MOST 109-2221-E-035-041-MY3Taichung Veterans General Hospital, Taiwan TCVGH-FCU1118202 and TCVGH-1115401C
6 · The paper itself

Abstract

ZnO nanowires and nanowalls can be fabricated on the glass substrate with a ZnO seed film and low-cost aluminum (Al) foil by the aqueous solution method (ASM), respectively. The different concentrations of ZnO precursors can use to control the densities of ZnO nanowalls. In addition, FESEM, FETEM, EDS, XRD, XPS, and CL were used to evaluate the characteristics of ZnO nanowalls. The ZnO nanowalls exhibited higher photocatalytic efficiency (99.4%) than that of ZnO nanowires (53.3%) for methylene blue (MB) degradation under UVC light irradiation at the ZnO precursors of 50 mM. This result is attributed to ZnO nanowalls with Al-doped, which can improve the separation of photogenerated electron-hole pairs for enhanced photocatalytic activity. In addition, ZnO nanowalls can also reveal higher photocatalytic activity for the degradation of tetracycline capsules (TC) rather than commercial ZnO nanopowder under UVC light irradiation. The superoxide and hydroxyl radicals play essential roles in the degradation of MB and TC solutions by the radical-trapping experiment. Furthermore, the ZnO nanowalls exhibit excellent recycling and reuse capacity for up to four cycles for the degradation of MB and TC. This study highlights the potential use of ZnO nanowalls directly grown on commercial and low-cost Al foil as noble metal-free photocatalysis.

Indexed as

aqueous solution methodmethylene bluereusabilitytetracyclineUVC lightZnO nanowallsZnO nanowires

Identifiers

PMID36556814
PMCPMC9780911
OpenAlexW4312140733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.